<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142965">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01962584</url>
  </required_header>
  <id_info>
    <org_study_id>150/13</org_study_id>
    <nct_id>NCT01962584</nct_id>
  </id_info>
  <brief_title>CMR in Patients With Myocarditis</brief_title>
  <official_title>Value of CMR Including T1 Mapping in Patients With Acute Myocarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <authority>Ethics Commission: University of Bonn</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the additive values of T1 mapping in patients with acute myocarditis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac magnetic resonance (CMR) is an established non-invasive diagnostic tool for acute
      and chronic myocarditis. Established CMR criteria for diagnosing myocarditis are edema on
      black-blood T2-weighted imaging, relative contrast enhancement seen on T1-weighted imaging
      for assessment of hyperemia, and late contrast-agent enhancement seen with inversion
      recovery late enhancement technique for visualization of myocardial fibrosis.

      Recently, tissue characterization based on calculation of myocardial T1 relaxation time (T1
      mapping) as well as T1-derived extracellular volume fraction has become available. Recently,
      reference values for myocardial T1 relaxation times at 3T for healthy volunteers were
      published for CMR. However, to date no comprehensive data for multiparametric CMR in
      patients with suspected myocarditis at 3 Tesla is available. Therefore, the purpose of this
      prospective study was to evaluate the diagnostic value of CMR at 3T in patients with
      suspected acute myocarditis using a multiparametric CMR approach including T1 mapping as
      novel tool for tissue characterization.

      CMR will be performed within 7 days after hospital admission for &quot;suspected acute
      myocarditis&quot;.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>T1 relaxation times</measure>
    <time_frame>time of CMR, CMR will be performed within 7 days after hospital admission for &quot;suspected acute myocardtitis&quot;.</time_frame>
    <safety_issue>No</safety_issue>
    <description>quantification of T1 relaxation times</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extracellular volume (ECV)</measure>
    <time_frame>time of CMR, CMR will be performed within 7 days after hospital admission for &quot;suspected acute myocardtitis&quot;.</time_frame>
    <safety_issue>No</safety_issue>
    <description>calculation of extracellular volume based on T1 relaxation time</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Suspected Acute Myocarditis</condition>
  <arm_group>
    <arm_group_label>SAM</arm_group_label>
    <description>patients with suspected acute myocarditis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HC</arm_group_label>
    <description>Healthy controls</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with suspected acute myocarditis and otherwise unremarkable cardiac history
        exclusion of CAD in invasive coronary angiography
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with suspected acute myocarditis and otherwise unremarkable cardiac history

        Exclusion Criteria:

          -  exclusion of CAD in invasive coronary angiography

          -  pregnancy

          -  contraindications for MR imaging
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claas P Naehle, MD</last_name>
    <phone>+49-228-287</phone>
    <phone_ext>15963</phone_ext>
    <email>cp@naehle.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julian Luetkens, MD</last_name>
    <phone>+49-228-287</phone>
    <phone_ext>15963</phone_ext>
    <email>julian.luetkens@ukb.uni-bonn.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Bonn</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claas P Naehle, MD</last_name>
      <phone>+49-228-287</phone>
      <phone_ext>15963</phone_ext>
      <email>cp@naehle.net</email>
    </contact>
    <contact_backup>
      <last_name>Julian Luetkens, MD</last_name>
      <phone>+49-228-287</phone>
      <phone_ext>15963</phone_ext>
      <email>julian.luetkens@ukb.uni-bonn.de</email>
    </contact_backup>
    <investigator>
      <last_name>Claas P Naehle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 9, 2013</lastchanged_date>
  <firstreceived_date>October 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Bonn</investigator_affiliation>
    <investigator_full_name>Claas P. Naehle</investigator_full_name>
    <investigator_title>section chief cardicvascular imaging</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
